TOP 30 Bladder cancer research in Rochester, New York

4 results found

Jonathan Bloom, MD is a reputable doctor specializing in urology, located at 156 West Avenue in Brockport, New York, United States. Dr. Bloom is also affiliated with other medical facilities at 10 South Pointe Landing, Suite 130 and 158 Sawgrass Drive, 2nd Floor, Suite 230 in Rochester, NY. He is an Assistant Professor of Clinical Urology in the Department of Urology at the School of Medicine and Dentistry. Dr. Bloom completed his Fellowship in Urologic Oncology at the National Cancer Institute/National Institute of Health and his Residency in Urology at New York Medical College. He also holds an MD from SUNY Downstate Medical Center College of Nursing. Dr. Bloom has published several research articles in prestigious medical journals, focusing on topics such as prostate cancer, renal ischemia/reperfusion injury, and bladder cancer. He is also a co-author of chapters in medical textbooks related to prostate cancer imaging and urothelial malignancies of the upper urinary tract.

Edward Messing, MD is a renowned institution located at 158 Sawgrass Drive, 2nd Floor, Suite 230, Brighton, New York, United States. Dr. Edward Messing specializes in urology and has received numerous awards and accolades for his clinical research and contributions to the field. With a residency in Urology from Stanford University School of Medicine and extensive experience in surgery, Dr. Messing is a trusted expert in the medical community. His research on bladder cancer, renal tumors, and other urological conditions has been widely published and recognized. Patients can trust in the expertise and dedication of Dr. Edward Messing for their urological health needs.

Kevin Bylund, MD is a doctor specializing in Radiation Oncology located at 1000 South Avenue, Rochester, New York, United States. Dr. Bylund is an Associate Professor in the Department of Radiation Oncology at the University of Rochester School of Medicine and Dentistry. He has received multiple awards for his research in the field of oncology. Dr. Bylund's expertise includes treating high risk prostate cancer and low gene risk score patients with less intense hormone therapy and radiation therapy. He has also conducted research on the use of angiotensin converting enzyme inhibitors to reduce late bladder toxicity following radiotherapy for prostate cancer.

Kevin Bylund, MD is an institution located at 601 Elmwood Avenue in Rochester, New York, United States. Dr. Bylund is an Associate Professor in the Department of Radiation Oncology at the University of Rochester Medical Center. He completed his Residency in Radiation Oncology at the University of Rochester Medical Center and his Internship in Internal Medicine at St. Louis University School of Medicine/Medical Center. Dr. Bylund has received multiple awards for his research in the field of oncology. The institution offers a variety of services including treatment for high-risk prostate cancer, research on reducing bladder toxicity following radiotherapy, and building high-dose-rate prostate brachytherapy programs. Dr. Bylund has also conducted research on the utility of topical agents for radiation dermatitis and pain, as well as the prognostic significance of sites of visceral metastatic disease in prostate cancer.